InfuSystem Holdings, Inc. (NYSEAMERICAN:INFU) Shares Sold by Teton Advisors Inc.

Teton Advisors Inc. lowered its holdings in InfuSystem Holdings, Inc. (NYSEAMERICAN:INFU) by 2.5% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 195,000 shares of the medical instruments supplier’s stock after selling 5,000 shares during the quarter. Teton Advisors Inc.’s holdings in InfuSystem were worth $2,055,000 as of its most recent filing with the SEC.

Other institutional investors also recently made changes to their positions in the company. First Eagle Investment Management LLC boosted its stake in shares of InfuSystem by 29.6% during the 3rd quarter. First Eagle Investment Management LLC now owns 468,400 shares of the medical instruments supplier’s stock worth $4,515,000 after acquiring an additional 107,001 shares in the last quarter. Heartland Advisors Inc. raised its holdings in InfuSystem by 17.6% during the third quarter. Heartland Advisors Inc. now owns 500,000 shares of the medical instruments supplier’s stock worth $4,820,000 after purchasing an additional 75,000 shares during the last quarter. Punch & Associates Investment Management Inc. boosted its position in InfuSystem by 3.2% during the third quarter. Punch & Associates Investment Management Inc. now owns 939,918 shares of the medical instruments supplier’s stock worth $9,061,000 after purchasing an additional 28,807 shares in the last quarter. Citigroup Inc. grew its holdings in InfuSystem by 124.1% in the third quarter. Citigroup Inc. now owns 50,640 shares of the medical instruments supplier’s stock valued at $488,000 after purchasing an additional 28,038 shares during the last quarter. Finally, WINTON GROUP Ltd purchased a new position in shares of InfuSystem in the third quarter valued at $101,000. 71.13% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Separately, StockNews.com cut shares of InfuSystem from a “strong-buy” rating to a “buy” rating in a research report on Monday.

InfuSystem Stock Down 6.0 %

Shares of INFU traded down $0.49 during trading hours on Monday, reaching $7.63. 23,945 shares of the company traded hands, compared to its average volume of 43,762. The firm has a market cap of $162.21 million, a P/E ratio of 254.42 and a beta of 1.24. InfuSystem Holdings, Inc. has a fifty-two week low of $7.57 and a fifty-two week high of $11.44. The company has a quick ratio of 1.54, a current ratio of 1.95 and a debt-to-equity ratio of 0.56.

About InfuSystem

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.